A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules

Clinical trial NCT04440176 · COMPLETED

Trial details

NCT number: NCT04440176
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningococcal Vaccine

Start date: 2020-06-17
Primary completion: 2024-01-05
Enrollment: 309

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.